TCTMD spoke with Batchelor about how executive orders on DEI and federal funding are impacting the research ecosystem.

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

Bushra Sumra’s career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...

Session explores innovation in operationalizing clinical trials and how challenges with adoption can be addressed.

A Simulation training is an interactive, scenario-based learning approach designed to enhance the capacity of stakeholders involved in combating human trafficking. It replicates real-life situations ...

Tomorrows, a global health technology company connecting patients and physicians with all possible pre-approval treatment options, today announced the launch of its next-generation AI platform.

Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...

Valerio Therapeutics is ending all clinical trials, including an ongoing phase 1/2 study for its investigational “DNA decoy” ...

The U.S. Food and Drug Administration (FDA), and the Office of Human Research protections (OHRP) released draft guidance titled, “Considerations ...

The University of Southern California has been approved for $10.8 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI) to compare approaches to treating older adults ...